In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
BO-2727, a new injectable carbapenem, was evaluated for its in vitro and in vivo antibacterial activities in comparison with those of biapenem, meropenem, imipenem, cefpirome, and ceftazidime. BO-2727 had activity comparable to that of imipenem against methicillin-susceptible staphylococci and strep...
Сохранить в:
| Опубликовано в:: | Antimicrob Agents Chemother |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
1995
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7625784/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.5.1030 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
